De novo variants of DEAF1 cause intellectual disability in six Chinese patients

Shimeng Chen,Xiaolu Deng,Juan Xiong,Fang He,Lifen Yang,Baiyu Chen,Chen Chen,Ciliu Zhang,Li Yang,Jing Peng,Fei Yin

DOI: https://doi.org/10.1016/j.cca.2021.02.026

IF: 6.314

2021-07-01

Clinica Chimica Acta

Abstract:BACKGROUND: It has been reported that de novo heterozygous variants of DEAF1 can cause DEAF1-associated neurodevelopmental disorder. The purpose of this article is to explore the clinical and genetic characteristics of Chinese patients harboring de novo DEAF1 variants.METHODS: We assembled a cohort of six unrelated patients with de novo variants in DEAF1. Clinical and genetic features of these patients were summarized.RESULTS: Each child showed intellectual disability (ID)/ global developmental delay (GDD). Severe language impairment was prominent. Behavior problems, seizures, sleep disturbance, and a high pain threshold were common features. DEAF1-related seizures were reported to be difficult to treat or intractable. Seizures in our cohort were almost all treatable. Valproic acid was the most commonly used drug. Five heterozygous missense mutations of DEAF1 gene were identified, three of which (p.W234C, p.L203P, p.H275Q) were not published in literature before.CONCLUSION: Mutations of DEAF1 gene should be considered in ID/GDD patients with a nonspecific phenotype, comprising intellectual disability, prominent speech delay, abnormal behaviors, especially autism. In our study, DEAF1-related epilepsy is completely treatable in Eastern-Asian individuals when compared to patients in other regions, and valproic acid can be used as a first choice. The knowledge of DEAF1-related neurodevelopmental disorder and the de novo variant database of DEAF1 were expanded.

medical laboratory technology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the clinical and genetic characteristics of Chinese patients carrying DEAF1 gene de novo variants. Specifically, the research aims to: 1. **Describe the clinical phenotypes of Chinese patients carrying DEAF1 gene de novo variants**: including symptoms such as Intellectual Disability (ID), Global Developmental Delay (GDD), severely impaired language development, behavioral problems (such as autistic features), sleep disorders, high pain threshold, and recurrent infections. 2. **Summarize the genotypic characteristics of these patients**: five heterozygous missense mutations identified by Whole - Exome Sequencing (WES), among which three are newly discovered mutation sites (p.W234C, p.L203P, p.H275Q). 3. **Explore the relationship between genotype and phenotype**: analyze the effects of different mutations on the functional domains of the DEAF1 protein (especially the SAND domain), and explain how these mutations lead to neurodevelopmental disorders. 4. **Compare the differences between the East Asian population and populations in other regions**: pay special attention to the differences in the treatment effects of antiepileptic drugs (AEDs), and the frequency differences of certain specific phenotypes (such as the interest in rotating objects). ### Research Background It has been previously reported that de novo heterozygous variants of the DEAF1 gene can lead to DEAF1 - associated neurodevelopmental disorder. This study further expands the understanding in this field, especially systematically describes the clinical and genetic characteristics of such patients in the Chinese population for the first time. ### Main Conclusions - **Clinical manifestations**: All patients showed varying degrees of intellectual disability or global developmental delay, severely impaired language development, and most were accompanied by autistic features and other behavioral problems. - **Genotype**: Five different heterozygous missense mutations were discovered, among which three were newly discovered mutation sites. - **Treatment response**: Compared with previous studies, patients in the East Asian region had a better response to antiepileptic drugs (especially Valproic acid), and the epileptic symptoms of most patients were effectively controlled. - **Phenotypic differences**: Patients in the East Asian region had less interest in rotating objects, while this feature was more common in patients in other regions. Through these studies, the authors hope to provide more reference basis for the clinical diagnosis and treatment of patients carrying DEAF1 gene de novo variants, and lay the foundation for further research on the mechanism of DEAF1 - associated neurodevelopmental disorders.

De novo variants of DEAF1 cause intellectual disability in six Chinese patients

De novo and biallelic DEAF1 variants cause a phenotypic spectrum

Functional Analysis of Novel DEAF1 Variants Identified Through Clinical Exome Sequencing Expands DEAF1-associated Neurodevelopmental Disorder (DAND) Phenotype.

A Heterozygous Missense Variant in the YWHAG Gene Causing Developmental and Epileptic Encephalopathy 56 in a Chinese Family.

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

A heterozygous variant of FGF13 caused X-linked developmental and epileptic encephalopathy 90 in a Chinese family

Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene

Genetic analysis of developmental and epileptic encephalopathy caused by novel biallelic SZT2 gene mutations in three Chinese Han infants: a case series and literature review

Further Delineation of EBF3-related Syndromic Neurodevelopmental Disorder in Twelve Chinese Patients

Novel Loss-of-Function Variants in CHD2 Cause Childhood-Onset Epileptic Encephalopathy in Chinese Patients

Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review

[Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay]

Case report: Identification of a recurrent pathogenic DHDDS mutation in Chinese family with epilepsy, intellectual disability and myoclonus

Genetic and phenotypic analysis of 225 Chinese children with developmental delay and/or intellectual disability using whole-exome sequencing

Case Report: A developmental and epileptic encephalopathy 45 due to de novo variant of GABRB1

Synonymous variants in the ATP6AP2 gene may lead to developmental and epileptic encephalopathy

Early Onset Developmental Delay and Epilepsy in Pediatric Patients with WDR45 Variants.

SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures